StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
Huagongshe Open Project:[email protected]KI-Anbindung: llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.7.8
Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 97653Erstellt: 3. November 2026

Dichlorotrimethylantimon

Nsc140285 · Trimethyldichlorostibine · Trimethyldichloroantimony · Dichlorotrimethylantimony · Antimony,dichlorotrimethyl- · Antimony, dichlorotrimethyl- · Trimethyldichloroantimony(V) · Dichlorotrimethylantimony(V)

https://huagongshe.com/de/chemical/97653

Molekülstruktur von Dichlorotrimethylantimon

Identifikatoren & physikalische Daten

CAS No.13059-67-1
SummenformelC3H9Cl2Sb
Durchschnittliche Molmasse237,77 g/mol
Monoisotopische Masse235,91194 g/mol
SMILES[CH3][Sb]([CH3])([CH3])([Cl])[Cl]
InChIKeyIEOZXTYTNPKDKQ-UHFFFAOYSA-L
PubChem CID97653
EC No.235-952-8
DTXSIDDTXSID80156630
Lokaler NameDichlorotrimethylantimon

Chemische & physikalische Eigenschaften

Polarare Oberfläche (TPSA)0
H-Brücken-Donoren0
H-Brücken-Akzeptoren0
Frei drehbare Bindungen0
Schwere Atome6
Formalladung0
Komplexität54,9
Schmelzpunkt222-223 °C (dec.)(lit.)

Sicherheit & Vorschriften

TreatmentFollowing oral exposure to antimony, administer charcoal as a slurry (240 mL water/30 g charcoal). Following inhalation exposure, move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with inhaled beta2 agonist and oral or parenteral corticosteroids. In case of eye exposure, irrigate exposed eyes with copious amounts of room temperature water for at least 15 minutes. Following dermal exposure, Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician may need to examine the area if irritation or pain persists. (T36)
Gesundheitliche AuswirkungenDermal exposure to antimony can cause antimony spots (papules and pustules around sweat and sebaceous glands). Antimony poisoning can also lead to pneumoconiosis. Alterations in pulmonary function and other effects including chronic bronchitis, chronic emphysema, inactive tuberculosis, pleural adhesions, and irritation can result from inhalation of antimony. Increased blood pressure can also result from antimony poisoning. Myocardial depression, vasodilation and fluid loss may cause shock with hypotension, electrolyte disturbances and acute renal failure. Cerebral oedema, coma, convulsions, and death are possible. (L741)
ExpositionspfadeInhalation (L741)oral (L741)dermal (L741)
ToxizitätsübersichtThe inhalation data suggests that the myocardium is a target of antimony toxicity. It is possible that antimony affects circulating glucose by interfering with enzymes of the glycogenolysis and gluconeogenesis pathways. The mechanism of action of antimony remains unclear. However, some studies suggest that antimony combines with sulfhydryl groups including those in several enzymes important for tissue respiration. The antidotal action of BAL depends on its ability to prevent or break the union between antimony and vital enzymes. Moreover, the The cause of death is believed to be essentially the same as that in acute arsenic poisoning. (T18, L741, A238)
Signs and SymptomsAbdominal pain, vomiting, diarrhea can result from inhalation of antimony. Dyspnea, headache, vomiting,cough, conjunctivitis, and bloody purulent discharge from nose can result from inhalation exposure. Skin or eye contact can cause pain and redness of the exposed surface. (T64, L741)
Carcinogen Classification
No indication of carcinogenicity (not listed by IARC). (L135)
Wassergefährdungsklasse (WGK)2
UN-TransportnummerUN 3261 8/PG 2
R-Sätze (R)20/22-34-51/53
GefahrensymboleC,N
Sicherheitshinweise (S)22-26-36/37/39-45-61